The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction. The VALIANT Echo Study

Journal of the American College of Cardiology

Volumn 50, Issue 13, 2007, Pages 1238-1245

  Verma, Anil ^a   Anavekar, Nagesh S ^b   Meris, Alessandra ^a   Thune, Jens Jakob ^a   Arnold, J Malcolm O ^c   Ghali, Jalal K ^d   Velazquez, Eric J ^e   McMurray, John J V ^f   Pfeffer, Marc A ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d WAYNE STATE UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART RIGHT VENTRICLE FUNCTION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORPHOLOGY; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SYSTOLE;

AGED; CARDIAC VOLUME; CREATININE; DIASTOLE; FEMALE; GLOMERULAR FILTRATION RATE; HEART ATRIA; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ULTRASONOGRAPHY, DOPPLER, COLOR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548654734     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.018     Document Type: Article

References (35)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
2. Hillege H.L., Nitsch D., Pfeffer M.A., et al., CHARM Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
3. Szczech L.A., Best P.J., Crowley E., et al., BARI Investigators. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105 (2002) 2253-2258
4. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
5. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
6. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
7. Foley R.N., Parfrey P.S., Harnett J.D., et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47 (1995) 186-192
8. Curtis B.M., and Parfrey P.S. Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. Cardiol Clin 23 (2005) 275-284
9. Pfeffer M.A., McMurray J.J., Velazquez E.J., et al., VALIANT Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
10. Solomon S.D., Skali H., Anavekar N.S., et al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation 111 (2005) 3411-3419
11. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
12. Helmcke F., Nanda N.C., Hsiung M.C., et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75 (1987) 175-183
13. Singh J.P., Evans J.C., Levy D., et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83 (1999) 897-902
14. Chen C.G., Thomas J.D., Anconina J., et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation 84 (1991) 712-720
15. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
17. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
18. St. John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89 (1994) 68-75
19. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
20. Gaudron P., Eilles C., Ertl G., and Kochsiek K. Early remodelling of the left ventricle in patients with myocardial infarction. Eur Heart J 11 (1990) 139-146
21. Nishimura R., and Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 30 (1997) 8-18
22. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90 (2002) 1284-1289
23. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Risks for atrial fibrillation and congestive heart failure in patients ≥65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 93 (2004) 54-58
24. Pritchett A.M., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J., Karon B.L., and Redfield M.M. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 45 (2005) 87-92
25. Stewart G.A., Gansevoort R.T., Mark P.B., et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 67 (2005) 217-226
26. London G.M. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17 (2002) 29-36
27. Aurigemma G.P., and Gaasch W.H. Clinical practice. Diastolic heart failure. N Engl J Med 351 (2004) 1097-1105
28. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part 1: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
29. Gaasch W.H., and Zile M.R. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55 (2004) 373-394
30. Amann K., and Ritz E. The heart in renal failure: morphological changes of the myocardium-new insights. J Clin Basic Cardiol 4 (2001) 109-113
31. Mall G., Huther W., Schneider J., Lundin P., and Ritz E. Diffuse intermyocardiocytic fibrosis in uaremic patients. Nephrol Dial Transplant 5 (1990) 39-44
32. McMahon A.C., Naqvi R.U., Hurst M.J., Raine A.E., and MacLeod K.T. Diastolic dysfunction and abnormality of the Na+/Ca2+ exchanger in single uremic cardiac myocytes. Kidney Int 69 (2006) 846-851
33. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
34. Solomon S.D., Glynn R.J., Greaves S., et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 134 (2001) 451-458
35. Ho C.Y., and Solomon S.D. A clinician's guide to tissue Doppler imaging. Circulation 113 (2006) e396-e398